| 2025-12-03 |
股东大会：
将于2025-12-22召开股东大会
会议内容 ▼▲
- 1.The election of seven directors for a term of one year;
2.The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025;
3.Approve an amendment to the Company’s 2019 Employee Stock Purchase Plan to increase the number of shares issuable by 250,000 shares and increase the number of shares subject to a Purchase Right thereunder to 10,000;
4.Approve an amendment to the Company’s 2016 Incentive Plan to increase the number of shares issuable by Mustang Bio, Inc. by 2,500,000 shares;
5.The transaction of any other business that may properly come before the Annual Meeting or any adjournment of the Annual Meeting.
|
| 2025-11-07 |
详情>>
股本变动：
变动后总股本729.91万股
变动原因 ▼▲
- 原因：
- From June 30, 2025 to September 30, 2025
Issuance of common shares, equity fee on At-the-Market and equity offerings
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.32美元,归母净利润-138.3万美元,同比去年增长90.66%
|
| 2025-09-29 |
详情>>
内部人交易：
Fortress Biotech, Inc.股份增加59334.00股
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益-0.27美元,归母净利润-91.5万美元,同比去年增长93.17%
|
| 2025-05-14 |
详情>>
业绩披露：
2025年一季报每股收益-0.05美元,归母净利润-15.3万美元,同比去年增长97.05%
|
| 2025-03-28 |
详情>>
业绩披露：
2024年年报每股收益-38.57美元,归母净利润-1575.2万美元,同比去年增长69.47%
|
| 2025-01-28 |
复牌提示：
2025-01-28 10:58:42 停牌，复牌日期 2025-01-28 11:08:42
|
| 2025-01-16 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2024-12-06 |
股东大会：
将于2024-12-26召开股东大会
会议内容 ▼▲
- 1.The election of seven directors for a term of one year;
2.The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024;
3.The transaction of any other business that may properly come before the Annual Meeting or any adjournment of the Annual Meeting.
|
| 2024-11-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.62美元,归母净利润-1480万美元,同比去年增长65.57%
|
| 2024-08-13 |
详情>>
业绩披露：
2024年中报每股收益-0.78美元,归母净利润-1339万美元,同比去年增长59.34%
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.46美元,归母净利润-519.1万美元,同比去年增长68.90%
|
| 2024-03-11 |
详情>>
业绩披露：
2023年年报每股收益-6美元,归母净利润-5160.2万美元,同比去年增长33.44%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-5.29美元,归母净利润-4298.6万美元,同比去年增长25.75%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-4.06美元,归母净利润-3292.8万美元,同比去年增长15.34%
|
| 2023-04-28 |
股东大会：
将于2023-06-21召开股东大会
会议内容 ▼▲
- 1.The election of six directors for a term of one year;
2.The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2023;
3.An advisory vote to approve the compensation of our named executive officers in this proxy statement;
4.An advisory vote to approve the frequency with which we will hold an advisory vote on the compensation of our named executive officers;
5.An amendment to the Company’s 2019 Employee Stock Purchase Plan to increase the number of shares issuable by 400,000 shares and increase the number of shares subject to a Purchase Right thereunder to 5,000;
6.The transaction of any other business that may properly come before the Annual Meeting or any adjournment of the Annual Meeting.
|
| 2023-04-04 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2022-04-29 |
股东大会：
将于2022-06-21召开股东大会
会议内容 ▼▲
- 1.Elect six directors for a term of one year;
2.Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2022;
3.Approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized shares of common stock by 50,000,000 shares from 150,000,000 to 200,000,000;
4.Approve an amendment to the Company’s 2016 Incentive Plan to increase the number of shares issuable by Mustang Bio, Inc. by 3,000,000 shares;
5.Transact any other business that may properly come before the Annual Meeting or any adjournment of the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-17召开股东大会
会议内容 ▼▲
- 1.Elect six directors for a term of one year;
2.Ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for the year ending December 31, 2021;
3.Consider a shareholder proposal on an amendment to the Company’s articles/bylaws to require majority vote in director elections;
4.Amendment of the Amended and Restated Certificate of Incorporation to Increase Authorized Shares of Common Stock by 25,000,000 shares from 125,000,000 to 150,000,000;
5.Amendment to the Company’s 2016 Incentive Plan to Increase the Number of Shares Issuable by Mustang Bio, Inc. by 3,000,000 shares;
6.Amendment to the Company’s 2019 Employee Stock Purchase Plan to increase the number of shares issuable by 600,000 shares;
7.Transact any other business that may properly come before the Annual Meeting or any adjournment of the Annual Meeting.
|
| 2020-06-04 |
股东大会：
将于2020-06-17召开股东大会
会议内容 ▼▲
- 1.Elect six directors for a term of one year;
2.Ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for the year ending December 31, 2020;
3.Consider a shareholder proposal on an amendment to the Company’s articles/bylaws to require majority vote in director elections;
4.Transact any other business that may properly come before the Annual Meeting or any adjournment of the Annual Meeting.
|
| 2019-04-30 |
股东大会：
将于2019-06-18召开股东大会
会议内容 ▼▲
- 1.Elect six directors for a term of one year;
2.Ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for the year ending December 31, 2019;
3.Approve our 2019 Employee Stock Purchase Plan;
4.Transact any other business that may properly come before the Annual Meeting or any adjournment of the Annual Meeting.
|
| 2018-04-30 |
股东大会：
将于2018-06-14召开股东大会
会议内容 ▼▲
- 1.Elect six directors for a term of one year;
2.Ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for the year ending December 31, 2018;
3.To approve an amendment to our 2016 Incentive Plan to increase the number of authorized shares issuable by 3,000,000 shares;
4.Approve an amendment to our Amended and Restated Certificate of Incorporation to amend the annual stock dividend due date from March 13 to January 1;
5.Transact any other business that may properly come before the Annual Meeting or any adjournment of the Annual Meeting.
|